Erwan Bourlès has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A lyophilised formulation of chimpanzee adenovirus vector for long-term stability outside the deep-freeze cold chain

    by Frédéric Mathot, Edwige Lefebvre, Bernard G. Francq, Delphine Guillaume, Erwan Bourlès

    Background The adenovirus-vaccine platform has come to prominence with the COVID-19 vaccination campaigns. The objective of this study was to validate a formulation that was suitable for lyophilisation and long-term storage at 5 (2–8) °C. Methods Vaccine stability was assessed up to five years at 5 °C using a lyophilised formulation of the chimpanzee-adenovirus vector ChAd155 encoding a respiratory syncytial virus (RSV) antigen. Vaccine potency was assessed by functional infectivity assay. Other assessments of vaccine stability included those for capsid integrity, particle content, and DNA release. Vaccine efficacy and safety were assessed after two years in a murine model of RSV challenge and a rabbit toxicology model, respectively. Results Here, we show that the potency loss from lyophilisation was 0.12 log10. The potency loss over five years at 5 °C was estimated at 0.21 log10 (95%CI 0.10–0.30). This coincides with a 25% increase in the ratio of non-infectious particles/infectious particles. After two years of storage at 5 °C, (i) the loss of infectivity was 0.17 log10; (ii) the vaccine remained immunogenic and effective at clearing RSV from the lungs in a mouse-challenge model; and (iii) the vaccine was not associated with any adverse safety signal in a rabbit toxicology model. Conclusions The 5-year stability of the lyophilised adenovirus-vector vaccine is within our acceptable limit ( < 0.3 log10 decrease). Its formulation process is amenable to manufacturing scale-up and should help in providing adenovirus-based vaccines where the cold chain is problematic, such as in low-income countries, and in pre-epidemic stockpiling.


  • Open Access

    Analysis of the Shear Stresses in a Filling Line of Parenteral Products: The Role of Fittings

    by Camilla Moino, Bernadette Scutellà, Marco Bellini, Erwan Bourlès, Gianluca Boccardo, Roberto Pisano

    Fill-finish of parenteral formulations represents a crucial step in the pharmaceutical industry that necessitates careful monitoring of product stability down the line. Shear stress and interfacial stress are two elements that threaten product stability, the respective contributions of which are still up for debate. This article focuses on the analysis of shear stress in the sampling phase of the filling line. Specifically, Computational Fluid Dynamics (CFD) simulations were employed to determine the shear stress distribution experienced by a protein-based parenteral drug as it passes through sampling fittings of various shapes under laminar and turbulent regime conditions. Rather than seeking the specific mechanism triggering the destabilization of a product, an attempt was made to analyze the fluid dynamics within these fittings and offer further understanding of the resulting shear stress. In addition, information was collected on the product path within the fittings, which allowed the identification of equations suitable for describing the shear stress distribution. The proposed approaches made it possible to consider the actual flowrate subjected to a given shear stress at a given time. Finally, a comparison was drawn with respect to the fluid dynamics within classical straight tubing to outline differences. This study revealed that the shear stress experienced within the fittings was higher than that in the tubing. Moreover, significant differences were reported in the T-fitting case under turbulent conditions.


  • Open Access

    Analysis of the Shear Stresses in a Filling Line of Parenteral Products: The Role of Tubing

    by Camilla Moino, Bernadette Scutellà, Marco Bellini, Erwan Bourlès, Gianluca Boccardo, Roberto Pisano

    Parenteral products appear to be sensitive to process conditions in bioprocessing steps, such as interfacial stress and shear stress. The combination of these elements is widely believed and proven to influence product stability, but the defined roles of these players in the product damage process have not yet been identified. The present work addresses a current industrial problem, by focusing on the analysis of shear stress on protein-based therapeutics flowing in tubing by means of Computational Fluid Dynamics simulations. The purpose of this article is not to pinpoint the mechanism triggering the damage of the product, but it represents the first step towards wider experimental investigations and introduces a new strategy to quantify the average shear stress. The field of scale-down approaches, used to scale the commercial process down to the laboratory level, is also explored. Since quality control is critical in the pharmaceutical realm, it is essential that the scale-down approach preserves the same stress exposure as the commercial scale, which in the present work is considered to be that resulting from shear effects. Therefore, a new approach for scaling down the commercial process is proposed, which has been compared with traditional approaches and shown to provide greater representativeness between the two scales.


  • Open Access

    Surface Treatment of Glass Vials for Lyophilization: Implications for Vacuum-Induced Surface Freezing

    by Francesco Regis, Andrea Arsiccio, Erwan Bourlès, Bernadette Scutellà, Roberto Pisano

    Freeze-drying is commonly used to increase the shelf-life of pharmaceuticals and biopharmaceuticals. Freezing represents a crucial phase in the freeze-drying process, as it determines both cycle efficiency and product quality. For this reason, different strategies have been developed to allow for a better control of freezing, among them, the so-called vacuum-induced surface freezing (VISF), which makes it possible to trigger nucleation at the same time in all the vials being processed. We studied the effect of different vial types, characterized by the presence of hydrophilic (sulfate treatment) or hydrophobic (siliconization and TopLyo Si–O–C–H layer) inner coatings, on the application of VISF. We observed that hydrophobic coatings promoted boiling and blow-up phenomena, resulting in unacceptable aesthetic defects in the final product. In contrast, hydrophilic coatings increased the risk of fogging (i.e., the undesired creeping of the product upward along the inner vial surface). We also found that the addition of a surfactant (Tween 80) to the formulation suppressed boiling in hydrophobic-coated vials, but it enhanced the formation of bubbles. This undesired bubbling events induced by the surfactant could, however, be eliminated by a degassing step prior to the application of VISF. Overall, the combination of degasification and surfactant addition seems to be a promising strategy for the successful induction of nucleation by VISF in hydrophobic vials.


  • Development of freeze-drying cycle via design space approach: a case study on vaccines

    by Bernadette Scutellà, Erwan Bourlès

    Freeze-drying is a dehydration process that provides improved stability of vaccine formulations during shipment and storage. During the primary drying steps of the process, product temperature has to be maintained below a critical value to avoid visual defects of the product, leading to an increase of the sublimation time and thus of the operational costs. In this work, we used the design space approach together with experimental analysis for the development of the primary drying step of a vaccine model formulation. First, the formulation was characterized by determining the glass transition temperature and the collapse temperature. Successively, the dynamic design space of primary drying was calculated via mathematical modelling, and a proven acceptable range (PAR) was defined around the selected operating values. Finally, the cycle and PAR were validated by performing a freeze-drying cycle at pilot scale and by evaluating the values of the product critical quality attributes (e.g. moisture content, visual aspect).


  • Scale-Up of Freeze-Drying Cycles, the Use of Process Analytical Technology (PAT), and Statistical Analysis

    by Erwan Bourlès, Gael de Lannoy, Bernadette Scutellà, Fernanda Fonseca, Ioan Cristian Trelea, Stephanie Passot


  • Open Access

    Use of a multi-vial mathematical model to design freeze-drying cycles for pharmaceuticals at known risk of failure

    by Bernadette Scutellà, Ioan Cristian Trelea, Erwan Bourlés, Fernanda Fonseca, Stephanie Passot

    Freeze-drying is a dehydration method suitable for the stabilization of heat-labile pharmaceutical products, such as vaccines. Due to the vial-to-vial variability of heat and mass transfer during the process, the value of the critical process parameters (e.g., product temperature, sublimation rate) may be different between vials and batches often present significant product quality heterogeneity. The aim of this work was the development of a dynamic, multi-vial mathematical model making it possible to predict risk of failure of the process, defined as the percentage of vials potentially rejected by quality inspection. This tool could assist the design of freeze-drying cycle. Keywords: lyophilization; vaccines; heat and mass transfer; mathematical modeling; design space